Amgen Inc
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Amgen Inc is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Amgen Inc in the same report. This provides an indication of potential competitors or associated to Amgen Inc. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016

Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016


2016-12-14
GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3998CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3998CTIDB
  • View Report: Research and Experts Market Report: Usher Syndrome - Pipeline Review, H2 2016

    Usher Syndrome - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome – Pipeline Review, H2 2016, provides an overview of the Usher Syndrome (Genetic Disorders) pipeline landscape.

    Usher syndrome is an inherited...

  • Market Report
  • Genetic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8903IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8903IDB
  • View Report: Research and Experts Market Report: Merkel Cell Carcinoma - Pipeline Review, H2 2016

    Merkel Cell Carcinoma - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Merkel Cell Carcinoma (Oncology) pipeline landscape.

    Merkel cell carcinoma is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8896IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8896IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease – Pipeline Review, H2 2016, provides an overview of the Anemia in Chronic Kidney Disease (Hematological Disorders) pipeline...
  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8849IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8849IDB
  • View Report: Research and Experts Market Report: Dysphagia Global Clinical Trials Review, H2, 2016

    Dysphagia Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, H2, 2016" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3948CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3948CTIDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine...

    Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0687TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0687TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein...

    Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0686TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0686TDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016

    Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Pipeline Review, H2 2016’, provides in depth analysis on Thrombopoietin Receptor (Myeloproliferative Leukemia...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0681TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0681TDB
  • View Report: Research and Experts Market Report: Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or...

    Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016’, provides in depth analysis on Induced Myeloid...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0677TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0677TDB
  • View Report: Research and Experts Market Report: Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review,...

    Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review, H2 2016’, provides in depth analysis on Potassium Voltage Gated Channel Subfamily...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0676TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0676TDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H2 2016

    Breast Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Breast Cancer – Pipeline Review, H2 2016, provides an overview of the Breast Cancer (Oncology) pipeline landscape.

    Breast cancer is a cancer that develops from...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8871IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8871IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) – Pipeline Review, H2 2016, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape.

    Retinit...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8828IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8828IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome (Sjogren) – Pipeline Review, H2 2016, provides an overview of the Sicca Syndrome (Sjogren) (Immunology) pipeline landscape.

    Sjogren's syndrome...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8821IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8821IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016

    Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Nonseminomatous Testicular Cancer clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3882CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3882CTIDB
  • View Report: Research and Experts Market Report: Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

    Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3881CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3881CTIDB
  • View Report: Research and Experts Market Report: Bone Metastasis Global Clinical Trials Review, H2, 2016

    Bone Metastasis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2016" provides an overview of Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3880CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3880CTIDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0672TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0672TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H2 2016

    Liposarcoma - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liposarcoma – Pipeline Review, H2 2016, provides an overview of the Liposarcoma (Oncology) pipeline landscape.

    Liposarcoma is a malignant tumor of fatty tissue....

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8815IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8815IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline...

    Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016’, provides in depth analysis on Transient Receptor Potential Cation...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0655TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0655TDB
  • View Report: Research and Experts Market Report: Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H2 2016

    Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0642TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0642TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

    Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Extrahepatic Bile Duct Cancer clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3873CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3873CTIDB
  • View Report: Research and Experts Market Report: Intestinal Cancer Global Clinical Trials Review, H2, 2016

    Intestinal Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3866CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3866CTIDB
  • View Report: Research and Experts Market Report: Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3865CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3865CTIDB
  • View Report: Research and Experts Market Report: Angiosarcoma Global Clinical Trials Review, H2, 2016

    Angiosarcoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma....
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3864CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3864CTIDB
  • View Report: Research and Experts Market Report: Hematological Tumor Global Clinical Trials Review, H2, 2016

    Hematological Tumor Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3862CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3862CTIDB
  • View Report: Research and Experts Market Report: Renal Failure Global Clinical Trials Review, H2, 2016

    Renal Failure Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure....
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3859CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3859CTIDB
  • View Report: Research and Experts Market Report: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

    End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3858CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3858CTIDB
  • View Report: Research and Experts Market Report: Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016

    Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016’, provides in depth analysis on Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0639TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0639TDB
  • View Report: Research and Experts Market Report: T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

    T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016’, provides in depth analysis on T Cell Surface Glycoprotein CD3 Epsilon Chain (T...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0633TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0633TDB
  • View Report: Research and Experts Market Report: Diacylglycerol O Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT Related Gene Product 1 or Acyl CoA Retinol O Fatty Acyltransferase...

    Diacylglycerol O Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT Related Gene Product 1 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT1 or EC 2.3.1.76 or EC 2.3.1.20) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Diacylglycerol O Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT Related Gene Product 1 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT1 or EC 2.3.1.76 or EC 2.3.1.20) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0628TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0628TDB
  • View Report: Research and Experts Market Report: Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016

    Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2016’, provides in depth analysis on Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0624TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0624TDB
  • View Report: Research and Experts Market Report: Aplastic Anemia - Pipeline Review, H2 2016

    Aplastic Anemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape.

    Aplastic anemia is a syndrome...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8733IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8733IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Industry Report: Global Biotechnology

    Global Biotechnology


    2016-11-25
    Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Global
  • $350.00
  • Report 05IK-OHME8005 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME8005
  • View Report: Research and Experts Industry Report: Biotechnology in the United States

    Biotechnology in the United States


    2016-11-25
    Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Biotechnology
  • United States
  • $350.00
  • Report 05IK-OHME7977 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7977
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0611TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0611TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016

    Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0603TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0603TDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H2 2016

    Migraine - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8702IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8702IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016

    Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Bone Marrow Transplant Rejection clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3823CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3823CTIDB
  • View Report: Research and Experts Market Report: 20s Proteasome - Pipeline Review, H2 2016

    20s Proteasome - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘20s Proteasome - Pipeline Review, H2 2016’, provides in depth analysis on 20s Proteasome targeted pipeline therapeutics.

    The report provides comprehensive information on the 20s Proteasome , targeted therapeutics,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0595TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0595TDB
  • View Report: Research and Experts Market Report: Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

    Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016’, provides in depth analysis on Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0591TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0591TDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine...

    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0589TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0589TDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H2 2016

    Psoriatic Arthritis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8680IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8680IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H2 2016

    Thrombocytopenia - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia – Pipeline Review, H2 2016, provides an overview of the Thrombocytopenia (Hematological Disorders) pipeline landscape.

    Thrombocytopenia is...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8676IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8676IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis – Pipeline Review, H2 2016, provides an overview of the Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline landscape.

    Ankylosing...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8639IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8639IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3813CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3813CTIDB
  • View Report: Research and Experts Market Report: Dyslipidemia Global Clinical Trials Review, H2, 2016

    Dyslipidemia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, H2, 2016" provides an overview of Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyslipidemia....
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3809CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3809CTIDB
  • View Report: Research and Experts Market Report: Dermatomyositis Global Clinical Trials Review, H2, 2016

    Dermatomyositis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomyositis...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3806CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3806CTIDB
  • View Report: Research and Experts Market Report: Oral Mucositis Global Clinical Trials Review, H2, 2016

    Oral Mucositis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Oral Mucositis Global Clinical Trials Review, H2, 2016" provides an overview of Oral Mucositis clinical trials scenario. This report provides top line data relating to the clinical trials on Oral Mucositis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3804CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3804CTIDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

    Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3794CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3794CTIDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

    Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview of Secondary Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3792CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3792CTIDB
  • View Report: Research and Experts Market Report: Primary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

    Primary Hyperparathyroidism Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Primary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview of Primary Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3791CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3791CTIDB
  • View Report: Research and Experts Market Report: Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

    Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016’, provides in depth analysis on Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0578TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0578TDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H2 2016

    Gliosarcoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma – Pipeline Review, H2 2016, provides an overview of the Gliosarcoma (Oncology) pipeline landscape.

    Gliosarcoma is a type of brain tumor that originates...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8633IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8633IDB
  • View Report: Research and Experts Market Report: Atherosclerosis - Pipeline Review, H2 2016

    Atherosclerosis - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis – Pipeline Review, H2 2016, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape.

    Atherosclerosis (or arteriosclerotic...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8629IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8629IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016

    Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Axial Spondyloarthritis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3789CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3789CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025


    2016-08-08
    Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery occlusi...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC131PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC131PIDR
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H2 2016

    Osteoporosis - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis – Pipeline Review, H2 2016, provides an overview of the Osteoporosis (Metabolic Disorders) pipeline landscape.

    Osteoporosis, or thinning bones,...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8638IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2016

    Fallopian Tube Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer – Pipeline Review, H2 2016, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.

    Fallopian tube cancer is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8595IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8595IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Angina (Angina Pectoris) - Pipeline Review, H2 2016

    Angina (Angina Pectoris) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina – Pipeline Review, H2 2016, provides an overview of the Angina (Cardiovascular) pipeline landscape.

    Angina pectoris is a term that describes chest pain...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8578IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8578IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H2 2016

    Post Menopausal Osteoporosis - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis – Pipeline Review, H2 2016, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape.

    Postmenop...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8575IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8575IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Bone Metastasis - Pipeline Review, H2 2016

    Bone Metastasis - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis – Pipeline Review, H2 2016, provides an overview of the Bone Metastasis (Oncology) pipeline landscape.

    Bone metastasis occurs when cancer cells...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8543IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8543IDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection - Pipeline Review, H2 2016

    Kidney Transplant Rejection - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Transplant Rejection – Pipeline Review, H2 2016, provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape.

    Kidney transplantati...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8539IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8539IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Waldenstrom Macroglobulinemia – Pipeline Review, H2 2016, provides an overview of the Waldenstrom Macroglobulinemia (Oncology) pipeline landscape.

    Waldenstrom...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8527IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8527IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Chronic Heart Failure - Pipeline Review, H2 2016

    Chronic Heart Failure - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Heart Failure – Pipeline Review, H2 2016, provides an overview of the Chronic Heart Failure (Cardiovascular) pipeline landscape.

    Chronic heart failure...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8517IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8517IDB
  • View Report: Research and Experts Project Profile: Amgen, Inc. - Strategy, SWOT and Corporate Finance Report

    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report


    2016-12-27
    Amgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing...
  • Project Profile
  • Life Sciences
  • United States
  • $175.00
  • Report 05IK-95BA176A-A950-4E85-8588-C5 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-95BA176A-A950-4E85-8588-C5
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016

    Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2016" provides an overview of Left Ventricular Dysfunction clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3751CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3751CTIDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H2 2016

    Hypersensitivity - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypersensitivity,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8499IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8499IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Mycosis Fungoides Global Clinical Trials Review, H2, 2016

    Mycosis Fungoides Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3729CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3729CTIDB
  • View Report: Research and Experts Market Report: Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

    Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of Natural Killer Cell Lymphomas clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3727CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3727CTIDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

    Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3725CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3725CTIDB
  • View Report: Research and Experts Market Report: T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

    T-Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3718CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3718CTIDB
  • View Report: Research and Experts Market Report: Fanconi Anemia Global Clinical Trials Review, H2, 2016

    Fanconi Anemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Fanconi Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fanconi...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3711CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3711CTIDB
  • View Report: Research and Experts Market Report: Neutropenia Global Clinical Trials Review, H2, 2016

    Neutropenia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on Neutropenia. Report...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3705CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3705CTIDB
  • View Report: Research and Experts Market Report: Febrile Neutropenia Global Clinical Trials Review, H2, 2016

    Febrile Neutropenia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Febrile Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3704CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3704CTIDB
  • View Report: Research and Experts Market Report: Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016

    Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016" provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3702CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3702CTIDB
  • View Report: Research and Experts Market Report: Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016

    Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) clinical trials scenario. This...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3701CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3701CTIDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Systemic Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3699CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3699CTIDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

    Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016" provides an overview of Graft Versus Host Disease (GVHD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3697CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3697CTIDB
  • View Report: Research and Experts Market Report: Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3695CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3695CTIDB
  • View Report: Research and Experts Market Report: Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3694CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3694CTIDB
  • View Report: Research and Experts Market Report: Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016

    Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016’, provides in depth analysis on Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0525TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0525TDB
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016

    Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0516TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0516TDB
  • View Report: Research and Experts Market Report: Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

    Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016’, provides in depth analysis on Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0515TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0515TDB
  • View Report: Research and Experts Market Report: Celiac Disease - Pipeline Review, H2 2016

    Celiac Disease - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H2 2016’, provides an overview of the Celiac Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Celiac Disease,...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8529IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8529IDB
  • View Report: Research and Experts Market Report: Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2016

    Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2016’, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8449IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8449IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8423IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8423IDB
  • View Report: Research and Experts Market Report: Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

    Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016


    2016-09-14
    GlobalData's Medical Devices sector report, “Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

    The report provides comprehensive information...

  • Market Report
  • Pharmaceuticals
  • Global
  • $4,000.00
  • Report 05IC-GDME0223EPD has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDME0223EPD
  • View Report: Research and Experts Market Report: Dyslipidemia - Current and Future Players

    Dyslipidemia - Current and Future Players


    2015-05-05
    GlobalData has released its pharma report, “Dyslipidemia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dyslipidemia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1056FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1056FPR
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H2 2016

    Dyslipidemia - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H2 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8412IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8412IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8392IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8392IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H2 2016

    Osteoarthritis - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8387IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8387IDB
  • View Report: Research and Experts Market Report: Cat Allergy - Pipeline Review, H2 2016

    Cat Allergy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H2 2016’, provides an overview of the Cat Allergy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cat Allergy, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8385IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8385IDB
  • View Report: Research and Experts Market Report: Optic Neuropathy - Pipeline Review, H2 2016

    Optic Neuropathy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Optic Neuropathy - Pipeline Review, H2 2016’, provides an overview of the Optic Neuropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Optic Neuropathy,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8377IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8377IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H2 2016

    Anal Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2016’, provides an overview of the Anal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8370IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8370IDB
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H2 2016

    Osteosarcoma - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H2 2016’, provides an overview of the Osteosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8358IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8358IDB
  • View Report: Research and Experts Market Report: Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related...

    Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0463TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0463TDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.)...

    E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016’, provides in depth analysis on E3 Ubiquitin Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0462TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0462TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation...

    Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation Factor or TNF Related Activation Induced Cytokine or Osteoprotegerin Ligand or CD254 or TNFSF11) - Pipeline Review, H2 20


    2016-08-10
    Global Markets Direct’s, ‘Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation Factor or TNF Related Activation Induced Cytokine or Osteoprotegerin Ligand or CD254...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0457TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0457TDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016

    Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016’, provides in depth analysis on Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0456TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0456TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8355IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8355IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Allergic Asthma - Pipeline Review, H2 2016

    Allergic Asthma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Allergic Asthma - Pipeline Review, H2 2016’, provides an overview of the Allergic Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Allergic Asthma,...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8350IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8350IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8349IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8349IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H2 2016

    Hyperlipidemia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperlipidemia,...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8344IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8344IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H2 2016

    Atopic Dermatitis - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atopic...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8341IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8341IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8339IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8339IDB
  • View Report: Research and Experts Market Report: Vascular Calcification Global Clinical Trials Review, H2, 2016

    Vascular Calcification Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Vascular Calcification Global Clinical Trials Review, H2, 2016" provides an overview of Vascular Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Vascular Calcificat...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3609CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3609CTIDB
  • View Report: Research and Experts Market Report: Arterial Stiffness Global Clinical Trials Review, H2, 2016

    Arterial Stiffness Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Stiffness Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3589CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3589CTIDB
  • View Report: Research and Experts Market Report: Arterial Calcification Global Clinical Trials Review, H2, 2016

    Arterial Calcification Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Calcification Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Calcificat...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3586CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3586CTIDB
  • View Report: Research and Experts Market Report: Acute Heart Failure Global Clinical Trials Review, H2, 2016

    Acute Heart Failure Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2016" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3585CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3585CTIDB
  • View Report: Research and Experts Market Report: Spinal Cord Injury Global Clinical Trials Review, H2, 2016

    Spinal Cord Injury Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview of Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Cord Injury....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3561CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3561CTIDB
  • View Report: Research and Experts Market Report: Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016

    Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016


    2016-07-27
    ‘Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016’, provides in depth analysis on Beta Nerve Growth Factor (Beta NGF or NGF) targeted pipeline therapeutics.

    The report provides comprehensive information on the Beta Nerve...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0413TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0413TDB
  • View Report: Research and Experts Market Report: Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016

    Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016


    2016-07-27
    ‘Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016’, provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Angiopoietin 2 (Ang 2 or ANGPT2),...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0411TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0411TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016

    Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016


    2016-07-20
    ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016’, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline...
  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8264IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8264IDB
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction - Pipeline Review, H2 2016

    Left Ventricular Dysfunction - Pipeline Review, H2 2016


    2016-07-20
    ‘Left Ventricular Dysfunction - Pipeline Review, H2 2016’, provides an overview of the Left Ventricular Dysfunction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Left Ventricular...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8257IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8257IDB
  • View Report: Research and Experts Market Report: Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline...

    Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Macrophage Colony Stimulating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0386TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0386TDB
  • View Report: Research and Experts Market Report: Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2)...

    Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016’, provides in depth analysis on Granulocyte Macrophage...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0385TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0385TDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism - Pipeline Review, H2 2016

    Secondary Hyperparathyroidism - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H2 2016’, provides an overview of the Secondary Hyperparathyroidism pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Hormonal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8282IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8282IDB
  • View Report: Research and Experts Market Report: Acute Heart Failure - Pipeline Review, H2 2016

    Acute Heart Failure - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Acute Heart Failure pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Acute...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8234IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8234IDB
  • View Report: Research and Experts Market Report: Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016

    Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3513CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3513CTIDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0228TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0228TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline...

    Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase C (Aurora 3 or...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0214TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0214TDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1)...

    Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase B (Aurora...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0213TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0213TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review,...

    Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase A (Serine/Threonine-Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0212TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0212TDB
  • View Report: Research and Experts Market Report: Cell Division Cycle 7 Related Protein Kinase (CDC7-Related Kinase or HsCdc7 or EC 2.7.11.1) - Pipeline Review, H1 2016

    Cell Division Cycle 7 Related Protein Kinase (CDC7-Related Kinase or HsCdc7 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Cell Division Cycle 7 Related Protein Kinase (CDC7-Related Kinase or HsCdc7 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Cell Division Cycle 7 Related Protein Kinase (CDC7-Related...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0194TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0194TDB
  • View Report: Research and Experts Market Report: Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related...

    Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016’, provides in depth...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0185TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0185TDB
  • View Report: Research and Experts Market Report: Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016

    Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016’, provides in depth analysis on Thrombopoietin Receptor (Myeloproliferative Leukemia...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0183TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0183TDB
  • View Report: Research and Experts Market Report: Interleukin 15 (IL15) - Pipeline Review, H1 2016

    Interleukin 15 (IL15) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Interleukin 15 (IL15) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 15 (IL15) targeted pipeline therapeutics.

    The report provides comprehensive information on the Interleukin 15 (IL15),...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0125TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0125TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Lipodystrophy Global Clinical Trials Review, H1, 2016

    Lipodystrophy Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Lipodystrophy Global Clinical Trials Review, H1, 2016" provides an overview of Lipodystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Lipodystrophy....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3510CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3510CTIDB
  • View Report: Research and Experts Market Report: Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016

    Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3508CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3508CTIDB
  • View Report: Research and Experts Market Report: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016

    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3504CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3504CTIDB
  • View Report: Research and Experts Market Report: Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline...

    Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1)  - Pipeline Review, H1 2016’, provides in depth analysis on Transient Receptor Potential...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0154TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0154TDB
  • View Report: Research and Experts Market Report: Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review,...

    Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Pipeline Review, H1 2016’, provides in depth analysis on Potassium Voltage Gated Channel Subfamily...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0149TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0149TDB
  • View Report: Research and Experts Market Report: Diacylglycerol O-Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT-Related Gene Product 1 or Acyl-CoA Retinol O-Fatty-Acyltransferase...

    Diacylglycerol O-Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT-Related Gene Product 1 or Acyl-CoA Retinol O-Fatty-Acyltransferase or EC 2.3.1.20) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Diacylglycerol O-Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT-Related Gene Product 1 or Acyl-CoA Retinol O-Fatty-Acyltransferase or EC 2.3.1.20) - Pipeline Review, H1 2016’, provides in depth analysis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0104TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0104TDB
  • View Report: Research and Experts Market Report: Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016

    Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 2016’, provides in depth analysis on Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0103TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0103TDB
  • View Report: Research and Experts Market Report: T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016

    T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016’, provides in depth analysis on T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0060TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0060TDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016

    Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3499CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3499CTIDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3491CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3491CTIDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3485CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3485CTIDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Pain clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3481CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3481CTIDB
  • View Report: Research and Experts Market Report: Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

    Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis


    2016-05-01
    GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of this growth will come from immune checkpoint...
  • Market Report
  • Oncology
  • Global
  • $10,995.00
  • Report 05IC-GDHC057POA has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC057POA
  • View Report: Research and Experts Market Report: Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC...

    Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016’, provides in depth analysis on Proprotein Convertase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0250TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0250TDB
  • View Report: Research and Experts Market Report: Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2)...

    Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016’, provides in depth analysis on Granulocyte Macrophage...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0181TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0181TDB
  • View Report: Research and Experts Market Report: 20s Proteasome - Pipeline Review, H1 2016

    20s Proteasome - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘20s Proteasome - Pipeline Review, H1 2016’, provides in depth analysis on 20s Proteasome targeted pipeline therapeutics.

    The report provides comprehensive information on the 20s Proteasome , targeted therapeutics,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0134TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0134TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

    Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.46) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0117TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0117TDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Psoriasis - Current and Future Players

    Psoriasis - Current and Future Players


    2016-04-13
    GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1044FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1044FPR
  • View Report: Research and Experts Market Report: Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3480CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3480CTIDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3473CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3473CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024


    2016-04-13
    Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC119PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC119PIDR
  • View Report: Research and Experts Market Report: Hyperlipidemia Global Clinical Trials Review, H1, 2016

    Hyperlipidemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperlipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3465CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3465CTIDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

    Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3446CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3446CTIDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3444CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3444CTIDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia Global Clinical Trials Review, H1, 2016

    Hypercholesterolemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H1, 2016" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3436CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3436CTIDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3417CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3417CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Global Clinical Trials Review, H1, 2016

    Head And Neck Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3413CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3413CTIDB
  • View Report: Research and Experts Market Report: Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016

    Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4) - Pipeline Review, H1 2016’, provides in depth analysis on Complement C5 (C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0073TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0073TDB
  • View Report: Research and Experts Market Report: Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016

    Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen) - Pipeline Review, H1 2016’, provides in depth analysis on Hepatocyte Growth Factor (Hepatopoietin-A or Lung Fibroblast Derived Mitogen)...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0053TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0053TDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8171IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8171IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016

    Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016’, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8195IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8195IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016’, provides an overview of the Sicca Syndrome (Sjogren) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8187IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8187IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H1 2016

    Neuroendocrine Tumors - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2016’, provides an overview of the Neuroendocrine Tumors pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8174IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8174IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8168IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8168IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0093TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0093TDB
  • View Report: Research and Experts Market Report: Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18...

    Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016’, provides in depth analysis on Folate Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0076TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0076TDB
  • View Report: Research and Experts Market Report: Mixed Dyslipidemia - Pipeline Review, H1 2016

    Mixed Dyslipidemia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Mixed Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Mixed Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mixed...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8141IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8141IDB
  • View Report: Research and Experts Market Report: Aplastic Anemia - Pipeline Review, H1 2016

    Aplastic Anemia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Aplastic Anemia - Pipeline Review, H1 2016’, provides an overview of the Aplastic Anemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Aplastic Anemia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8112IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8112IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma Global Clinical Trials Review, H1, 2016

    Ewing Sarcoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Ewing Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3409CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3409CTIDB
  • View Report: Research and Experts Market Report: Testicular Cancer Global Clinical Trials Review, H1, 2016

    Testicular Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3408CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3408CTIDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016

    Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3407CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3407CTIDB
  • View Report: Research and Experts Market Report: Gallbladder Cancer Global Clinical Trials Review, H1, 2016

    Gallbladder Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3406CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3406CTIDB
  • View Report: Research and Experts Market Report: Esophageal Cancer Global Clinical Trials Review, H1, 2016

    Esophageal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3405CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3405CTIDB
  • View Report: Research and Experts Market Report: Gastric Cancer Global Clinical Trials Review, H1, 2016

    Gastric Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3402CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3402CTIDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer Global Clinical Trials Review, H1, 2016

    Peritoneal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3400CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3400CTIDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma Global Clinical Trials Review, H1, 2016

    Burkitt Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3397CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3397CTIDB
  • View Report: Research and Experts Market Report: Laryngeal Cancer Global Clinical Trials Review, H1, 2016

    Laryngeal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Laryngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3395CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3395CTIDB
  • View Report: Research and Experts Market Report: Anal Cancer Global Clinical Trials Review, H1, 2016

    Anal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3392CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3392CTIDB
  • View Report: Research and Experts Market Report: Hyperparathyroidism Global Clinical Trials Review, H1, 2016

    Hyperparathyroidism Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3391CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3391CTIDB
  • View Report: Research and Experts Market Report: Achromatopsia - Pipeline Review, H1 2016

    Achromatopsia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Achromatopsia - Pipeline Review, H1 2016’, provides an overview of the Achromatopsia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Achromatopsia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8087IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8087IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2016

    Migraine - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2016’, provides an overview of the Migraine pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8006IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8006IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2016

    Thrombocytopenia - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2016’, provides an overview of the Thrombocytopenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thrombocytopenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8023IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8023IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2016

    Psoriatic Arthritis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2016’, provides an overview of the Psoriatic Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8010IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8010IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H1 2016

    Gliosarcoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2016’, provides an overview of the Gliosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gliosarcoma, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8049IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8049IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8015IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8015IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Atherosclerosis - Pipeline Review, H1 2016

    Atherosclerosis - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2016’, provides an overview of the Atherosclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atherosclerosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7993IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7993IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2016

    Osteoporosis - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Osteoporosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoporosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7989IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7989IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016

    Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016" provides an overview of Waldenstrom Macroglobulinemia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3387CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3387CTIDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

    Psoriatic Arthritis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H1, 2016" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3384CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3384CTIDB
  • View Report: Research and Experts Market Report: Osteopenia Global Clinical Trials Review, H1, 2016

    Osteopenia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H1, 2016" provides an overview of Osteopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Osteopenia. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3379CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3379CTIDB
  • View Report: Research and Experts Market Report: Osteoporosis Global Clinical Trials Review, H1, 2016

    Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoporosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3378CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3378CTIDB
  • View Report: Research and Experts Market Report: Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016

    Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016’, provides in depth analysis on Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0010TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0010TDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

    Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0002TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0002TDB
  • View Report: Research and Experts Market Report: Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

    Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0001TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0001TDB
  • View Report: Research and Experts Market Report: Angina (Angina Pectoris) - Pipeline Review, H1 2016

    Angina (Angina Pectoris) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Angina (Angina Pectoris) - Pipeline Review, H1 2016’, provides an overview of the Angina (Angina Pectoris) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7876IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7876IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H1 2016

    Post Menopausal Osteoporosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7873IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7873IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2016

    Fallopian Tube Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7816IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2016

    Ulcerative Colitis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ulcerative...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7601IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7601IDB
  • View Report: Research and Experts Market Report: Nasal Polyps Global Clinical Trials Review, H1, 2016

    Nasal Polyps Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H1, 2016" provides an overview of Nasal Polyps clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyps....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3359CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3359CTIDB
  • View Report: Research and Experts Market Report: Osteonecrosis Global Clinical Trials Review, H1, 2016

    Osteonecrosis Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Osteonecrosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteonecrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteonecrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3335CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3335CTIDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3334CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3334CTIDB
  • View Report: Research and Experts Market Report: Celiac Disease - Pipeline Review, H1 2016

    Celiac Disease - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H1 2016’, provides an overview of the Celiac Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Celiac Disease,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7846IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7846IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7840IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7840IDB
  • View Report: Research and Experts Market Report: Chronic Heart Failure - Pipeline Review, H1 2016

    Chronic Heart Failure - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Chronic Heart Failure pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7839IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7839IDB
  • View Report: Research and Experts Market Report: Bone Metastasis - Pipeline Review, H1 2016

    Bone Metastasis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2016’, provides an overview of the Bone Metastasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bone Metastasis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7833IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7833IDB
  • View Report: Research and Experts Market Report: Kidney Transplantation - Pipeline Review, H1 2016

    Kidney Transplantation - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Kidney Transplantation - Pipeline Review, H1 2016’, provides an overview of the Kidney Transplantation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7832IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7832IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2016

    Esophageal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2016’, provides an overview of the Esophageal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Esophageal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7704IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7704IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2016

    Peritoneal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2016’, provides an overview of the Peritoneal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Peritoneal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7697IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7697IDB
  • View Report: Research and Experts Market Report: Sinusitis - Pipeline Review, H1 2016

    Sinusitis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H1 2016’, provides an overview of the Sinusitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sinusitis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7746IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7746IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

    Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3328CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3328CTIDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016

    Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3320CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3320CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024


    2016-02-02
    The head and neck cancer (HNC) market is one currently dominated by generic chemotherapies, with little competition from branded therapies. The market landscape is set to undergo substantial growth between 2014 and 2024. The main drivers of growth will...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC054POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC054POA
  • View Report: Research and Experts Market Report: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016

    Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3306CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3306CTIDB
  • View Report: Research and Experts Industry Report: Biotechnology in the United States

    Biotechnology in the United States


    2015-02-12
    Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Biotechnology
  • United States
  • $350.00
  • Report 05IK-OHEC3242 has a star rating of 3.5 out of 5
  • Go to More information on Report 05IK-OHEC3242
  • View Report: Research and Experts Industry Report: Biotechnology in Canada

    Biotechnology in Canada


    2015-02-12
    Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Canada
  • $350.00
  • Report 05IK-OHEC3232 has a star rating of 3.5 out of 5
  • Go to More information on Report 05IK-OHEC3232
  • View Report: Research and Experts Industry Report: Biotechnology in the United States

    Biotechnology in the United States


    2016-01-18
    Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including...
  • Industry Report
  • Biotechnology
  • United States
  • $350.00
  • Report 05IK-OHME4729 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME4729
  • View Report: Research and Experts Market Report: Cat Allergy - Pipeline Review, H1 2016

    Cat Allergy - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H1 2016’, provides an overview of the Cat Allergy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cat Allergy, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7794IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7794IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7732IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7732IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2016

    Dyslipidemia - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7652IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7652IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7552IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7552IDB
  • View Report: Research and Experts Market Report: Dysphagia Global Clinical Trials Review, H1, 2016

    Dysphagia Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, H1, 2016" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3285CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3285CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hodgkin

    OpportunityAnalyzer: Hodgkin's Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Hodgkin’s lymphoma (HL), or Hodgkin’s disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all new cancer cases, but overall...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC052POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC052POA
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H1 2016

    Osteosarcoma - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2016’, provides an overview of the Osteosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7808IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7808IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H1 2016

    Anal Cancer - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2016’, provides an overview of the Anal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7766IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7766IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: B-Cell Non-Hodgkin

    OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen....
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC018POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC018POA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Company Report: Genentech, Inc. - Medical Equipment - Deals and Alliances Profile

    Genentech, Inc. - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Genentech, Inc. (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medica...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME4341D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME4341D
  • View Report: Research and Experts Company Report: AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile

    AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company’s products are used to treat...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME430057D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME430057D
  • View Report: Research and Experts Company Report: GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

    GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabol...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME4279D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME4279D
  • View Report: Research and Experts Company Report: Teva Pharmaceutical Industries Limited (TEVA) - Medical Equipment - Deals and Alliances Profile

    Teva Pharmaceutical Industries Limited (TEVA) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Teva Pharmaceutical Industries Ltd. ( (Teva) is a pharmaceutical company, which focuses on the development, manufacture and marketing of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and therapeutic...
  • Company Report
  • Medical Devices
  • Israel
  • $250.00
  • Report 05IB-GDME33504D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME33504D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile

    Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME32190D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME32190D
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile

    Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME24864D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME24864D
  • View Report: Research and Experts Company Report: Genzyme Corporation - Medical Equipment - Deals and Alliances Profile

    Genzyme Corporation - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. The company’s products and services focuses on rare genetic disorders, kidney diseases,...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME13D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME13D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

    Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Iron and steel Construction
  • United States
  • $125.00
  • Report 05IB-GDPH32190FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH32190FSA
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Iron and steel Construction
  • Switzerland
  • $125.00
  • Report 05IB-GDPH24864FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH24864FSA
  • View Report: Research and Experts Company Report: Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review

    Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review


    2016-02-23
    Teva Pharmaceutical Industries Ltd. ( (Teva) is a pharmaceutical company, which focuses on the development, manufacture and marketing of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and therapeutic...
  • Company Report
  • Iron and steel Construction
  • Israel
  • $125.00
  • Report 05IB-GDPH33504FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH33504FSA
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7660IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7660IDB
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H1 2016

    Hyperlipidemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperlipidemia,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7653IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7653IDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism - Pipeline Review, H1 2016

    Secondary Hyperparathyroidism - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2016’, provides an overview of the Secondary Hyperparathyroidism pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7614IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7614IDB
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction - Pipeline Review, H1 2016

    Left Ventricular Dysfunction - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H1 2016’, provides an overview of the Left Ventricular Dysfunction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7554IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7554IDB
  • View Report: Research and Experts Market Report: Acute Heart Failure - Pipeline Review, H1 2016

    Acute Heart Failure - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Acute Heart Failure pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Acute...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7553IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7553IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Sjögren

    OpportunityAnalyzer: Sjögren's Syndrome - Opportunity Analysis and Forecast to 2024


    2015-12-19
    Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary glands, resulting...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC048POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC048POA
  • View Report: Research and Experts Market Report: Joint Pain Global Clinical Trials Review, H1, 2016

    Joint Pain Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H1, 2016" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3216CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3216CTIDB
  • View Report: Research and Experts Market Report: Melanoma Global Clinical Trials Review, H1, 2016

    Melanoma Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3214CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3214CTIDB
  • View Report: Research and Experts Market Report: Sezary Syndrome Global Clinical Trials Review, H1, 2016

    Sezary Syndrome Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3210CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3210CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023

    OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023


    2015-12-01
    The main drivers of growth in graft versus host disease over the 2013-2023 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM.

    Sa...

  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC014EPOA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC014EPOA
  • View Report: Research and Experts Market Report: Portal Hypertension Global Clinical Trials Review, H1, 2016

    Portal Hypertension Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3198CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3198CTIDB
  • View Report: Research and Experts Company Report: American Bio Medica Corporation (ABMC) - Product Pipeline Analysis, 2016 Update

    American Bio Medica Corporation (ABMC) - Product Pipeline Analysis, 2016 Update


    2016-07-05
    American Bio Medica Corporation (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing (POCT) product that detects 1-10 drugs of abuse...
  • Company Report
  • Medical Devices
  • United States
  • $750.00
  • Report 05IC-GDME1077PD has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDME1077PD
  • View Report: Research and Experts Market Report: Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015

    Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-30
    Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Recurrent...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7252IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7252IDB
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H2 2015

    Osteosarcoma - Pipeline Review, H2 2015


    2015-10-30
    Osteosarcoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H2 2015’, provides an overview of the Osteosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7243IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7243IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2015

    Osteoarthritis Pain - Pipeline Review, H2 2015


    2015-10-30
    Osteoarthritis Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7221IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7221IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Renal Anemia - Pipeline Review, H2 2015

    Renal Anemia - Pipeline Review, H2 2015


    2015-10-30
    Renal Anemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Renal Anemia - Pipeline Review, H2 2015’, provides an overview of the Renal Anemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7230IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7230IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015


    2015-10-30
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7227IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7227IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015


    2015-10-30
    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7213IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7213IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Hepatic (Liver) Metastasis - Pipeline Review, H2 2015

    Hepatic (Liver) Metastasis - Pipeline Review, H2 2015


    2015-10-21
    Hepatic (Liver) Metastasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hepatic (Liver) Metastasis - Pipeline Review, H2 2015’, provides an overview of the Hepatic (Liver) Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7249IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7249IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H2 2015

    Esophageal Cancer - Pipeline Review, H2 2015


    2015-10-21
    Esophageal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6962IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6962IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-21
    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6843IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6843IDB
  • View Report: Research and Experts Market Report: Sinusitis - Pipeline Review, H2 2015

    Sinusitis - Pipeline Review, H2 2015


    2015-09-30
    Sinusitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H2 2015’, provides an overview of the Sinusitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7180IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7180IDB
  • View Report: Research and Experts Market Report: Cancer Cachexia - Pipeline Review, H2 2015

    Cancer Cachexia - Pipeline Review, H2 2015


    2015-09-30
    Cancer Cachexia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H2 2015’, provides an overview of the Cancer Cachexia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6977IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6977IDB
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H2 2015

    Hyperlipidemia - Pipeline Review, H2 2015


    2015-09-30
    Hyperlipidemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2015’, provides an overview of the Hyperlipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6969IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6969IDB
  • View Report: Research and Experts Market Report: Cachexia - Pipeline Review, H2 2015

    Cachexia - Pipeline Review, H2 2015


    2015-09-30
    Cachexia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cachexia - Pipeline Review, H2 2015’, provides an overview of the Cachexia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6965IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6965IDB
  • View Report: Research and Experts Market Report: Bone Metastasis - Pipeline Review, H2 2015

    Bone Metastasis - Pipeline Review, H2 2015


    2015-09-23
    Bone Metastasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H2 2015’, provides an overview of the Bone Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7089IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7089IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015


    2015-09-23
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7083IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7083IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2015

    Fallopian Tube Cancer - Pipeline Review, H2 2015


    2015-09-23
    Fallopian Tube Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7075IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7075IDB
  • View Report: Research and Experts Market Report: Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015

    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015


    2015-09-16
    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015’, provides an overview of the Gastroesophageal (GE) Junction Carcinomas’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7111IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7111IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H2 2015

    Anal Cancer - Pipeline Review, H2 2015


    2015-09-09
    Anal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7163IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7163IDB
  • View Report: Research and Experts Market Report: Cat Allergy - Pipeline Review, H2 2015

    Cat Allergy - Pipeline Review, H2 2015


    2015-09-09
    Cat Allergy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H2 2015’, provides an overview of the Cat Allergy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7158IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7158IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015


    2015-08-31
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6990IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6990IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction - Pipeline Review, H2 2015

    Left Ventricular Dysfunction - Pipeline Review, H2 2015


    2015-08-26
    Left Ventricular Dysfunction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H2 2015’, provides an overview of the Left Ventricular Dysfunction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7020IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7020IDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism - Pipeline Review, H2 2015

    Secondary Hyperparathyroidism - Pipeline Review, H2 2015


    2015-08-26
    Secondary Hyperparathyroidism - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H2 2015’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6996IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6996IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Malignant Glioma - Pipeline Review, H2 2015

    Malignant Glioma - Pipeline Review, H2 2015


    2015-07-31
    Malignant Glioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6872IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6872IDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H2 2015

    Recurrent Malignant Glioma - Pipeline Review, H2 2015


    2015-07-29
    Recurrent Malignant Glioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6884IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6884IDB
  • View Report: Research and Experts Market Report: Acute Heart Failure - Pipeline Review, H2 2015

    Acute Heart Failure - Pipeline Review, H2 2015


    2015-07-29
    Acute Heart Failure - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2015’, provides an overview of the Acute Heart Failure’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6881IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6881IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6509IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6509IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2015

    Osteoporosis - Pipeline Review, H1 2015


    2015-06-30
    Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6572IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6572IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Cancer Pain - Pipeline Review, H1 2015

    Cancer Pain - Pipeline Review, H1 2015


    2015-06-24
    Cancer Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2015’, provides an overview of the Cancer Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6696IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6696IDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia - Pipeline Review, H1 2015

    Hypercholesterolemia - Pipeline Review, H1 2015


    2015-06-24
    Hypercholesterolemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2015’, provides an overview of the Hypercholesterolemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6694IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6694IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2015

    Migraine - Pipeline Review, H1 2015


    2015-06-24
    Migraine - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6692IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6692IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H1 2015

    Gliosarcoma - Pipeline Review, H1 2015


    2015-06-17
    Gliosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2015’, provides an overview of the Gliosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6801IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6801IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma - Pipeline Review, H1 2015

    Ewing Sarcoma - Pipeline Review, H1 2015


    2015-06-10
    Ewing Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6716IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6716IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Epithelial Ovarian Cancer - Pipeline Review, H1 2015


    2015-05-29
    Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6521IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6521IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015


    2015-05-29
    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6520IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6520IDB
  • View Report: Research and Experts Market Report: Lung Adenocarcinoma - Pipeline Review, H1 2015

    Lung Adenocarcinoma - Pipeline Review, H1 2015


    2015-05-29
    Lung Adenocarcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H1 2015’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6718IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6718IDB
  • View Report: Research and Experts Market Report: Chronic Heart Failure - Pipeline Review, H1 2015

    Chronic Heart Failure - Pipeline Review, H1 2015


    2015-05-29
    Chronic Heart Failure - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2015’, provides an overview of the Chronic Heart Failure’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6597IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6597IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2015

    Psoriatic Arthritis - Pipeline Review, H1 2015


    2015-05-29
    Psoriatic Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2015’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6589IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6589IDB
  • View Report: Research and Experts Market Report: Renal Anemia - Pipeline Review, H1 2015

    Renal Anemia - Pipeline Review, H1 2015


    2015-05-29
    Renal Anemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Anemia - Pipeline Review, H1 2015’, provides an overview of the Renal Anemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6535IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6535IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015


    2015-05-29
    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6533IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6533IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015


    2015-05-29
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6532IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6532IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Sjogren

    Sjogren's Syndrome - Pipeline Review, H1 2015


    2015-05-20
    Sjogren's Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sjogren's Syndrome - Pipeline Review, H1 2015’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6744IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6744IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Anaplastic Astrocytoma - Pipeline Review, H1 2015


    2015-05-13
    Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6750IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6750IDB
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H1 2015

    Osteosarcoma - Pipeline Review, H1 2015


    2015-04-30
    Osteosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2015’, provides an overview of the Osteosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6549IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6549IDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis - Pipeline Review, H1 2015

    Post Menopausal Osteoporosis - Pipeline Review, H1 2015


    2015-04-29
    Post Menopausal Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Post Menopausal Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6630IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6630IDB
  • View Report: Research and Experts Market Report: Severe Psoriasis - Pipeline Review, H1 2015

    Severe Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Severe Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6610IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6610IDB
  • View Report: Research and Experts Market Report: Moderate Psoriasis - Pipeline Review, H1 2015

    Moderate Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Moderate Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Moderate Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6598IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6598IDB
  • View Report: Research and Experts Market Report: Menopausal Hot Flashes - Pipeline Review, H1 2015

    Menopausal Hot Flashes - Pipeline Review, H1 2015


    2015-04-15
    Menopausal Hot Flashes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Menopausal Hot Flashes - Pipeline Review, H1 2015’, provides an overview of the Menopausal Hot Flashes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6653IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6653IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-03-26
    Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Recurrent...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6414IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6414IDB
  • View Report: Research and Experts Market Report: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015

    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015


    2015-03-26
    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6413IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6413IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Sinusitis - Pipeline Review, H1 2015

    Sinusitis - Pipeline Review, H1 2015


    2015-03-19
    Sinusitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H1 2015’, provides an overview of the Sinusitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6442IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6442IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2015

    Fallopian Tube Cancer - Pipeline Review, H1 2015


    2015-03-19
    Fallopian Tube Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6248IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6248IDB
  • View Report: Research and Experts Market Report: Bone Metastasis - Pipeline Review, H1 2015

    Bone Metastasis - Pipeline Review, H1 2015


    2015-03-11
    Bone Metastasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2015’, provides an overview of the Bone Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6262IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6262IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-03-11
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6256IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6256IDB
  • View Report: Research and Experts Market Report: Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015


    2015-02-18
    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015’, provides an overview of the Gastroesophageal (GE) Junction Carcinomas’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6285IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6285IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Anal Cancer - Pipeline Review, H1 2015

    Anal Cancer - Pipeline Review, H1 2015


    2015-02-10
    Anal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6338IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6338IDB
  • View Report: Research and Experts Market Report: Cat Allergy - Pipeline Review, H1 2015

    Cat Allergy - Pipeline Review, H1 2015


    2015-02-10
    Cat Allergy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H1 2015’, provides an overview of the Cat Allergy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6333IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6333IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Left Ventricular Dysfunction - Pipeline Review, H1 2015

    Left Ventricular Dysfunction - Pipeline Review, H1 2015


    2015-01-30
    Left Ventricular Dysfunction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Left Ventricular Dysfunction - Pipeline Review, H1 2015’, provides an overview of the Left Ventricular Dysfunction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6197IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6197IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2015

    Esophageal Cancer - Pipeline Review, H1 2015


    2015-01-30
    Esophageal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6140IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6140IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism - Pipeline Review, H1 2015

    Secondary Hyperparathyroidism - Pipeline Review, H1 2015


    2015-01-30
    Secondary Hyperparathyroidism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2015’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6174IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6174IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015


    2015-01-30
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6168IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6168IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2015

    Indolent Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Indolent Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6162IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6162IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6158IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6158IDB
  • View Report: Research and Experts Market Report: Cancer Cachexia - Pipeline Review, H1 2015

    Cancer Cachexia - Pipeline Review, H1 2015


    2015-01-30
    Cancer Cachexia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H1 2015’, provides an overview of the Cancer Cachexia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6156IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6156IDB
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H1 2015

    Hyperlipidemia - Pipeline Review, H1 2015


    2015-01-30
    Hyperlipidemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2015’, provides an overview of the Hyperlipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6148IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6148IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015


    2015-01-30
    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015’, provides an overview of the Congestive Heart Failure (Heart Failure)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6130IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6130IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-01-30
    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6012IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6012IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2015

    Peritoneal Cancer - Pipeline Review, H1 2015


    2015-01-22
    Peritoneal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6120IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6120IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2015

    Ulcerative Colitis - Pipeline Review, H1 2015


    2015-01-22
    Ulcerative Colitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6015IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6015IDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Recurrent Malignant Glioma - Pipeline Review, H1 2015


    2015-01-22
    Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6070IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6070IDB
  • View Report: Research and Experts Market Report: Acute Heart Failure - Pipeline Review, H1 2015

    Acute Heart Failure - Pipeline Review, H1 2015


    2015-01-22
    Acute Heart Failure - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H1 2015’, provides an overview of the Acute Heart Failure’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6067IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6067IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6029IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6029IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2015

    Dyslipidemia - Pipeline Review, H1 2015


    2015-01-22
    Dyslipidemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6020IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6020IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Report: AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review


    2016-12-13
    AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company’s products are used to treat...
  • Company Report
  • Life Sciences
  • United States
  • $300.00
  • Report 05IC-GDPH430057FSA has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDPH430057FSA
  • View Report: Research and Experts Company Report: Astex Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

    Astex Pharmaceuticals, Inc. - Strategic SWOT Analysis Review


    2016-03-29
    Astex Pharmaceuticals, Inc. (Astex Pharmaceuticals), formerly SuperGen, Inc., is a novel drug discovery and development company, especially for cancer and central nervous system diseases. It discovers and develops small molecule treatments. The company’s...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH33284SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH33284SA
  • View Report: Research and Experts Company Report: ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review

    ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review


    2016-09-13
    ImmunoGen, Inc. (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH30222FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH30222FSA
  • View Report: Research and Experts Company Report: Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review

    Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review


    2016-09-20
    Mymetics Corporation (Mymetics) is a development stage biotechnology company which develops next-generation prophylactic vaccines for infectious diseases. It develops mucosal and virosomes based vaccines that help prevent HIV (AIDS) from crossing the...
  • Company Report
  • Life Sciences
  • Switzerland
  • $125.00
  • Report 05IC-GDPH62115FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH62115FSA
  • View Report: Research and Experts Company Report: Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review

    Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review


    2016-12-20
    Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH7218FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH7218FSA
  • View Report: Research and Experts Company Report: Regeneron Pharmaceuticals, Inc. (REGN) - Financial and Strategic SWOT Analysis Review

    Regeneron Pharmaceuticals, Inc. (REGN) - Financial and Strategic SWOT Analysis Review


    2016-04-26
    Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. It develops pharmaceutical products for the treatment of...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH81628FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH81628FSA
  • View Report: Research and Experts Company Report: Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review

    Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review


    2016-05-17
    Synta Pharmaceuticals Corp. (Synta) is a pharmaceutical company that discovers, develops and commercializes novel pharmaceutical products for the treatment of cancer and other severe medical conditions. It has a unique chemical compound, an integrated...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH82226FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH82226FSA
  • View Report: Research and Experts Company Report: Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review

    Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review


    2016-05-03
    Northwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. Using its proprie...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH62423FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH62423FSA
  • View Report: Research and Experts Company Report: Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review

    Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review


    2016-03-22
    Mabion SA (Mabion) is a biotechnology company that focuses on developing pharmaceutical products based on humanized monoclonal antibodies. It develops its therapeutic antibodies for the treatment of various cancers and autoimmune diseases. The company...
  • Company Report
  • Life Sciences
  • Poland
  • $125.00
  • Report 05IC-GDPH223431FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH223431FSA
  • View Report: Research and Experts Company Report: Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review

    Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review


    2016-05-03
    Navidea Biopharmaceuticals, Inc. (Navidea), is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. The company by utilizing its Manocept platform develops multiple...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH3740FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH3740FSA
  • View Report: Research and Experts Company Report: Ariad Pharmaceuticals, Inc. (ARIA) - Financial and Strategic SWOT Analysis Review

    Ariad Pharmaceuticals, Inc. (ARIA) - Financial and Strategic SWOT Analysis Review


    2016-04-19
    Ariad Pharmaceuticals Inc (Ariad) focuses on the discovery, development and marketing of small-molecule oncology therapies. Its products are indicated to treat chronic and acute leukemia, lung cancer and other difficult to treat cancers. The company’s...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH61132FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH61132FSA
  • View Report: Research and Experts Company Report: Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review

    Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review


    2016-03-29
    Emergent BioSolutions Inc. (Emergent) is a global specialty pharmaceutical company which focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH6940FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH6940FSA
  • View Report: Research and Experts Company Report: UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review

    UCB S.A. (UCB) - Financial and Strategic SWOT Analysis Review


    2016-04-12
    UCB S.A. (UCB) is a biopharmaceutical company that discovers and develops medicines and solutions to help treat various diseases. It focuses mainly on products for the treatment of central nervous system (CNS) and immunology related conditions. The core...
  • Company Report
  • Life Sciences
  • Belgium
  • $125.00
  • Report 05IC-GDPH33857FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH33857FSA
  • View Report: Research and Experts Company Report: Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review

    Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review


    2016-07-12
    Sangamo BioSciences, Inc. (Sangamo) is a clinical stage biopharmaceutical company which focuses on the the research and development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation and therapeutic genome editing. The...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH7227FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH7227FSA
  • View Report: Research and Experts Company Report: Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review

    Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review


    2015-03-23
    Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view...
  • Company Report
  • Pharmaceuticals
  • United States
  • $125.00
  • Report 05IC-GDPH3778FSA has a star rating of 3.5 out of 5
  • Go to More information on Report 05IC-GDPH3778FSA
  • View Report: Research and Experts Company Report: Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review

    Teva Pharmaceutical Industries Ltd. (TEVA) - Financial and Strategic SWOT Analysis Review


    2016-04-26
    Teva Pharmaceutical Industries Ltd. (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical...
  • Company Report
  • Life Sciences
  • Israel
  • $125.00
  • Report 05IC-GDPH33504FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH33504FSA
  • View Report: Research and Experts Company Report: Ligand Pharmaceuticals, Inc. (LGND) - Financial and Strategic SWOT Analysis Review

    Ligand Pharmaceuticals, Inc. (LGND) - Financial and Strategic SWOT Analysis Review


    2016-11-08
    Ligand Pharmaceuticals, Inc. (Ligand), formerly Progenx Inc., is a biopharmaceutical company develops and acquires technologies that help in discovery and development of medicines. The company offers a diversified portfolio of biotechnology and pharmaceut...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH59641FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH59641FSA
  • View Report: Research and Experts Company Report: Incyte Corporation (INCY) - Financial and Strategic SWOT Analysis Review

    Incyte Corporation (INCY) - Financial and Strategic SWOT Analysis Review


    2016-09-27
    Incyte Corporation (Incyte) is a biopharmaceutical company that discovers, develops, and commercializes proprietary cancer therapeutics. The company’s lead product, Jakafi (ruxolitinib) is marketed in the US for the treatment of patients with high-risk...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH40874FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH40874FSA
  • View Report: Research and Experts Company Report: Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review

    Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review


    2016-07-19
    Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company which focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH66520FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH66520FSA
  • View Report: Research and Experts Company Report: Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

    Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review


    2016-04-05
    Seattle Genetics, Inc. (Seattle Genetics) is a biotechnology company. It focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin)...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH4301FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH4301FSA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review

    F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review


    2016-10-12
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company that provides biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its products include medicines to treat cancers, brain diseases, viral and bacterial...
  • Company Report
  • Life Sciences
  • Switzerland
  • $125.00
  • Report 05IC-GDPH756FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH756FSA
  • View Report: Research and Experts Company Report: Genzyme Corporation - Strategic SWOT Analysis Review

    Genzyme Corporation - Strategic SWOT Analysis Review


    2016-08-02
    Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. The company’s products and services focuses on rare genetic disorders, kidney diseases,...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH13SA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH13SA
  • View Report: Research and Experts Market Report: Psoriasis Global Clinical Trials Review, H2, 2015

    Psoriasis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H2, 2015" provides an overview of Psoriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3000CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3000CTIDB
  • View Report: Research and Experts Market Report: Hypercalcemia Global Clinical Trials Review, H2, 2015

    Hypercalcemia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Hypercalcemia Global Clinical Trials Review, H2, 2015" provides an overview of Hypercalcemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercalcemia....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2998CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC2998CTIDB
  • View Report: Research and Experts Market Report: Mineral Deficiency Global Clinical Trials Review, H2, 2015

    Mineral Deficiency Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Mineral Deficiency Global Clinical Trials Review, H2, 2015" provides an overview of Mineral Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2997CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC2997CTIDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

    Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hyperphosphatemia In Chronic Kidney Disease clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2993CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC2993CTIDB
  • View Report: Research and Experts Market Report: Adenomas Global Clinical Trials Review, H2, 2015

    Adenomas Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Adenomas Global Clinical Trials Review, H2, 2015" provides an overview of Adenomas clinical trials scenario. This report provides top line data relating to the clinical trials on Adenomas. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2989CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC2989CTIDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015

    Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2987CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC2987CTIDB
  • View Report: Research and Experts Market Report: Bone Degeneration Global Clinical Trials Review, H2, 2015

    Bone Degeneration Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Bone Degeneration Global Clinical Trials Review, H2, 2015" provides an overview of Bone Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Bone...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2971CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC2971CTIDB
  • View Report: Research and Experts Market Report: Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015

    Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015" provides an overview of Polyarticular Idiopathic Juvenile Arthritis clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2959CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC2959CTIDB
  • View Report: Research and Experts Market Report: Amenorrhea Global Clinical Trials Review, H2, 2015

    Amenorrhea Global Clinical Trials Review, H2, 2015


    2015-12-09
    GlobalData's clinical trial report, “Amenorrhea Global Clinical Trials Review, H2, 2015" provides an overview of Amenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3051CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3051CTIDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015

    Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3022CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3022CTIDB
  • View Report: Research and Experts Industry Report: Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating...

    Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Produ


    2015-08-01
    Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost...
  • Industry Report
  • Biopharmaceuticals
  • Global
  • $3,400.00
  • Report 01B7-2015BM has a star rating of 4.5 out of 5
  • Go to More information on Report 01B7-2015BM
  • View Report: Research and Experts Market Report: Biosimilars Market - Forecast to 2021

    Biosimilars Market - Forecast to 2021


    2017-01-05
    Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application (Oncology, Blood Disorders) - Global Forecast...
  • Market Report
  • Biotechnology
  • Global
  • $5,650.00
  • Report 01L7-BT2160 has a star rating of 4.3 out of 5
  • Go to More information on Report 01L7-BT2160
  • View Report: Research and Experts Industry Report: GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer...

    GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells,


    2015-04-01
    This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in...
  • Industry Report
  • Therapeutics (pharmacology)
  • Global
  • $3,400.00
  • Report 01B7-2015CI has a star rating of 4.1 out of 5
  • Go to More information on Report 01B7-2015CI
  • View Report: Research and Experts Company Report: Amgen Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

    Amgen Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


    2012-02-06
    ICD Research's "Amgen Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business descripti...
  • Company Report
  • Pharmaceuticals
  • United States
  • $125.00
  • Report 01H3-ST03053CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-ST03053CP
  • Industries and Sectors

    • Dermatology (2)
    • Genetic Disorders... (1)
    • Oncology (73)
    • Hematological Disorders... (4)
    • Gastrointestinal... (5)
    • Pharmaceuticals (180)
    • Immunology (14)
    • Healthcare (4)
    • Genitourinary Disorders... (2)
    • Biotechnology (6)
    • Central Nervous... (3)
    • Musculoskeletal... (2)
    • Unassigned (8)
    • Metabolic Disorders... (10)
    • Cardiovascular (11)
    • Automotive (1)
    • Respiratory (2)
    • Life Sciences (149)
    • Hormonal Disorders... (1)
    • Iron and steel Construction... (17)
    • Medical Devices (9)
    • Biopharmaceuticals... (1)
    • Therapeutics (pharmacology)... (1)

    Geographic Regions

    • Global (466)
    • United States (28)
    • Canada (1)
    • Switzerland (5)
    • United Kingdom (1)
    • Israel (3)
    • Poland (1)
    • Belgium (1)

    Report Types

    • Market Report (463)
    • Industry Report (7)
    • Project Profile (1)
    • Company Report (35)

    Return to Company List

    Page created and rendered - Cache updated [3.80504s]